BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13679438)

  • 1. Attenuation of androgen receptor-dependent transcription by the serine/threonine kinase Pim-1.
    Thompson J; Peltola KJ; Koskinen PJ; Jänne OA; Palvimo JJ
    Lab Invest; 2003 Sep; 83(9):1301-9. PubMed ID: 13679438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.
    Linn DE; Yang X; Xie Y; Alfano A; Deshmukh D; Wang X; Shimelis H; Chen H; Li W; Xu K; Chen M; Qiu Y
    J Biol Chem; 2012 Jun; 287(27):22959-68. PubMed ID: 22584579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.
    Ha S; Iqbal NJ; Mita P; Ruoff R; Gerald WL; Lepor H; Taneja SS; Lee P; Melamed J; Garabedian MJ; Logan SK
    Oncogene; 2013 Aug; 32(34):3992-4000. PubMed ID: 22986532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.
    Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS
    Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
    Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
    Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation.
    Lee DK; Duan HO; Chang C
    J Biol Chem; 2001 Mar; 276(13):9978-84. PubMed ID: 11266437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
    Bhattacharyya RS; Krishnan AV; Swami S; Feldman D
    Mol Cancer Ther; 2006 Jun; 5(6):1539-49. PubMed ID: 16818513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
    Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
    J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
    Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
    Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer.
    Ruff SE; Vasilyev N; Nudler E; Logan SK; Garabedian MJ
    Commun Biol; 2021 Oct; 4(1):1221. PubMed ID: 34697370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transcriptional regulation of the androgen receptor by Mammalian target of rapamycin.
    Cinar B; De Benedetti A; Freeman MR
    Cancer Res; 2005 Apr; 65(7):2547-53. PubMed ID: 15805247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.
    Minges JT; Su S; Grossman G; Blackwelder AJ; Pop EA; Mohler JL; Wilson EM
    J Biol Chem; 2013 Jan; 288(3):1939-52. PubMed ID: 23172223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.
    Gordon V; Bhadel S; Wunderlich W; Zhang J; Ficarro SB; Mollah SA; Shabanowitz J; Hunt DF; Xenarios I; Hahn WC; Conaway M; Carey MF; Gioeli D
    Mol Endocrinol; 2010 Dec; 24(12):2267-80. PubMed ID: 20980437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
    Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
    J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.
    Li P; Lee H; Guo S; Unterman TG; Jenster G; Bai W
    Mol Cell Biol; 2003 Jan; 23(1):104-18. PubMed ID: 12482965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
    Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS
    Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.
    Nesslinger NJ; Shi XB; deVere White RW
    Cancer Res; 2003 May; 63(9):2228-33. PubMed ID: 12727844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.